Featured Business

NVOS Stock News: Latest Updates on Novo Integrated Sciences

nvos stock news

If you’ve searched “nvos stock news,” you’ve probably noticed the same problem everyone else runs into: half the data you find is stale, the price on one site doesn’t match the price on another, and the headlines swing between corporate updates and message-board chatter. NVOS (Novo Integrated Sciences, Inc.) is a small healthcare company that’s been through a lot in the last few years — a Nasdaq listing, a move to the OTC market, two reverse splits, and a string of financing announcements. This piece pulls that history together so you know what you’re actually looking at before you check a live quote.

This is not investment advice. It’s a plain-language rundown of what NVOS is, what’s driven its stock news in recent years, and where to verify the numbers yourself.

What Is NVOS Stock?

NVOS is the ticker for Novo Integrated Sciences, a Bellevue, Washington-based company built around Canadian and U.S. subsidiaries that provide primary care and rehabilitation services — physiotherapy, occupational therapy, and related wellness offerings — plus a smaller product-sales segment. It’s a micro-cap healthcare name, not a household brand, which is exactly why its stock behaves the way it does: thin trading, a low share count relative to its history, and a price that can move sharply on small volume.

For a broader company snapshot and the kind of volatility that’s followed the stock for years, the site’s analysis of NVOS stock volatility is a good starting point, and the comprehensive overview of Novo Integrated Sciences covers the business itself in more depth.

The Big NVOS Stock News Stories

nvos stock news

1. The move from Nasdaq to OTC markets

NVOS traded on the Nasdaq Capital Market for several years but no longer does — the stock now changes hands on the OTC market. That shift matters more than most single headlines, because it changes how the stock trades day to day: lower liquidity, wider gaps between the buy and sell price, and less analyst coverage. If you’re pulling a quote from an old bookmark or a cached financial page, double-check that it reflects the current OTC listing rather than a leftover Nasdaq feed, visit more.

2. Two reverse stock splits in three years

Novo has reduced its share count twice through reverse splits, both aimed at meeting exchange price requirements at the time.

Date  Ratio  Context 
February 1, 2021  1-for-10  Done ahead of an application to uplist to the Nasdaq Capital Market 
November 6, 2023  1-for-10  Done to regain compliance with Nasdaq’s minimum bid price rule 

Reverse splits don’t change the value of the company — they just consolidate shares so the per-share price rises proportionally. But a company that’s needed two of them in three years is telling you something about how persistently its share price has struggled to stay above listing minimums. The site’s full reverse split history and what it means breaks down each event in more detail.

3. Financing activity and dilution

Recent years of NVOS stock news include multiple securities purchase agreements, standby letter of credit programs, and board-approved share repurchase authorizations. These are common tools for a cash-constrained small-cap: raise money by issuing new shares or debt, and occasionally announce a buyback to signal confidence. The catch is that new share issuance dilutes existing holders, so it’s worth reading the actual SEC filing behind any financing headline rather than just the press release summary.

4. Leadership changes

NVOS has also seen changes at the executive level, including CEO transitions announced in company filings. Leadership turnover at a small-cap can precede a shift in strategy, so it’s usually worth tracking alongside the financial updates rather than in isolation.

5. Financial results

Novo’s most recent full fiscal year results showed revenue in the low double-digit millions with a net loss well above that figure — a pattern that’s fairly typical for a small healthcare operator still working toward consistent profitability. Quarterly and annual filings are the most reliable source here; third-party summaries sometimes lag by a quarter or more.

NVOS Stock Snapshot

Numbers on penny and micro-cap OTC stocks change fast and vary by data provider, so treat this table as a structural summary rather than a live quote.

Metric  What to know 
Exchange  OTC Markets (previously Nasdaq Capital Market) 
Sector  Healthcare services (physiotherapy, rehabilitation, wellness products) 
Share price history  Sub-$1, with two reverse splits since 2021 
Dividend  None 
Volatility  High — sharp daily swings are common on low volume 
Where to verify  OTC Markets, your broker’s live feed, or NVOS’s SEC filings 

Why NVOS Trades the Way It Does

A few structural factors explain most of the volatility you’ll see in NVOS stock news:

  • Low float and thin volume: Small share counts mean even modest buying or selling can move the price by double-digit percentages in a single session.
  • Retail-driven sentiment: With a low share price, NVOS attracts active retail trading, and chatter on trading forums can swing the stock as much as company fundamentals do. The site’s NVOS Stocktwits sentiment breakdown and what traders are saying now are useful companions if you want a sense of community mood alongside the news.
  • OTC illiquidity: Wider bid-ask spreads on OTC stocks mean the price you see quoted isn’t always the price you’ll actually get filled at.
  • Financing needs: Recurring capital raises are a normal part of the story for a company still scaling revenue, but they also mean share count can rise between quarters.

How to Track NVOS Stock News Going Forward

  • Check the live quote directly on OTC Markets or your broker’s feed, not a cached search snippet.
  • Confirm whether any number you’re reading is split-adjusted — older articles and outdated charts often aren’t.
  • Read the most recent SEC filings for cash position and share count; these tell you more about where the company stands than a single day’s price action.
  • Cross-reference sentiment sources like Nvos Stock Stocktwits with the actual press releases, since forum sentiment and company news don’t always move together.
  • If you want a forward-looking view rather than a news recap, the site’s NVOS stock forecast for 2026 lays out the price scenarios and risks in more depth.

FAQs

Is NVOS still listed on Nasdaq? 

No. NVOS now trades on the OTC market. It was previously listed on the Nasdaq Capital Market.

Why has NVOS done two reverse stock splits? 

Both splits — February 2021 and November 2023 — were done to meet Nasdaq’s minimum share price requirements at the time. Reverse splits reduce the number of outstanding shares and proportionally raise the price per share; they don’t change the underlying value of the company.

Does NVOS pay a dividend? 

No. NVOS does not currently pay a dividend to shareholders.

Why is NVOS stock so volatile? 

A combination of low trading volume, a low float, active retail sentiment, and OTC-market illiquidity means the price can move sharply on relatively small trades, visit more.

Where can I find official NVOS company announcements? 

The most reliable source is the company’s own SEC filings and press releases, which are also aggregated on financial data sites like OTC Markets, Nasdaq, and major brokerages.

Should I buy NVOS stock based on the news? 

That’s a decision only you (or a licensed financial advisor) can make based on your own research and risk tolerance. This article is meant to explain the news, not recommend a trade.

Conclusion

NVOS stock news over the past few years tells a fairly consistent story: a small healthcare company navigating a shift from Nasdaq to OTC trading, two reverse splits to manage its share price, recurring financing activity, and the kind of volatility that comes with all three. 

None of that is unusual for a micro-cap in this position, but it does mean the numbers you see on any given day need context. Before acting on a headline, check the primary filing behind it, confirm the quote is current, and weigh it against the company’s cash position rather than the day’s price swing alone.

James William

About Author